GLYCOMICS MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2024-2031)

Regional Analysis

To learn more about this report, request sample copy

North America has established itself as the dominant region in the global glycomics market and is anticipated to hold 45.8% of the market share in 2024. The U.S is one of the major market drivers due to significant investments in R&D activities by both public and private entities. Research funding from federal agencies such as National Institutes of Health (NIH) has propelled glycomics research, resulting in numerous innovative solutions. Additionally, collaboration between industry and academia has strengthened the overall research landscape. Regional firms are well-recognized globally for their expertise in developing novel enzymes, tools and assays that facilitate glycan analysis. This has enabled North America to be at the forefront in clinical applications of glycomics technologies.

Asia Pacific, on the other hand, has emerged as the fastest growing regional market worldwide. Countries, such as China, Japan and South Korea, have demonstrated high potential, especially in the biopharmaceutical manufacturing sector. The presence of established contract manufacturing organizations and lower operating costs have attracted pharmaceutical giants to set up manufacturing bases. This augurs well for glycomics as biologics development depends heavily on glycan analytics. Governments are proactively supporting life sciences by initiating favorable policies and research incentives. China, in particular, has poured billions of dollars in the last decade to develop its domestic capability across the MedTech, pharmaceutical, and healthcare sectors. Many regional firms have gained global reputation for providing high-quality bioanalytics services at competitive prices. Their capabilities around assay development, glycan sequencing, and expression analysis continue to expand. With economic growth accelerating research investments, Asia Pacific is clearly the next hotspot for glycomics opportunities.